ZURA: Zura Bio Limited Stock

by  •  • Comments Off on ZURA: Zura Bio Limited Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 82.73
Enterprise Value ($M) -74.63
Book Value ($M) 151.40
Book Value / Share 2.21
Price / Book 0.55
NCAV ($M) 150.60
NCAV / Share 2.20
Price / NCAV 0.55

Profitability (mra)
Return on Invested Capital (ROIC) -0.41
Return on Assets (ROA) -0.69
Return on Equity (ROE) -0.84

Liquidity (mrq)
Quick Ratio 8.14
Current Ratio 8.14

Balance Sheet (mrq) ($M)
Current Assets 171.69
Assets 172.50
Liabilities 21.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -55.19
Net Income -52.40
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -28.08
Cash from Investing -5.08
Cash from Financing 109.84

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Great Point Partners Llc 4.86 -2.86
02-14 13G/A Ra Capital Management, L.p. 4.90 0.00
02-14 13G/A ADAR1 Capital Management, LLC 3.18 -37.67
02-12 13G/A Pfizer Inc 4.60 0.00
11-14 13G/A Venrock Healthcare Capital Partners III, L.P. 9.99 7.09
11-14 13G/A Suvretta Capital Management, Llc 7.60 70.56
09-23 13G/A Athanor Capital, Lp 1.49
2024-04-22 13G/A Deep Track Capital, LP 9.34 47.83

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2025-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One)
2024-05-15 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-09 21,262 94,536 22.49
2025-05-08 36,937 336,710 10.97
2025-05-07 93,619 641,458 14.59
2025-05-06 104,993 516,412 20.33
2025-05-05 51,064 180,357 28.31

(click for more detail)

Similar Companies
WINT – Windtree Therapeutics, Inc. XBIO – Xenetic Biosciences, Inc.
XCUR – Exicure, Inc.


Financial data and stock pages provided by
Fintel.io